510(k) Report

FDA applicant

Medtox Diagnostics, Inc.

Burlington, NC22 decisions1998–20261 recall

FDA records 22 decisions for Medtox Diagnostics, Inc. (Burlington, NC) from 1998 to 2026: 22 510(k) clearances. Most are in product codes DJG (Enzyme Immunoassay, Opiates) and DIS (Enzyme Immunoassay, Barbiturate). Its devices cite 9 predicates, 5 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Medtox Diagnostics, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2010

2009: 22010: 22026 (partial year): 1
2007high 2 (2009) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Medtox Diagnostics, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Medtox Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report